UPDATE: Goldman Sachs Reduces PT to $16 on MAKO Surgical Following Common Stock Offering
Goldman Sachs reiterated its Neutral rating on MAKO Surgical (NASDAQ: MAKO) and reduced its price target from $17 to $16.
Goldman Sachs noted, "On Wednesday, November 14, MAKO Surgical completed a common stock offering of 3.04mn shares at $13.15 per share. This compares to the November 13 closing price of $13.21. We note that shares of MAKO were down 9.1% on November 13 vs. the Russell 2000 down 0.6% ahead of the company's announced offering that was issued after the market close. We update our model for a higher share count as well as the cash inflow associated with the secondary share issuance (approximately $45mn). … The completed financing removes a risk, as the company should maintain a cash cushion."
MAKO Surgical closed at $13.21 on Tuesday.
Latest Ratings for MAKO
|Sep 2013||Wells Fargo||Downgrades||Outperform||Market Perform|
|Sep 2013||Summer Street||Downgrades||Buy||Neutral|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.